Tirzepatide Buy Online here today for research at the competitive price of $160.00. We supply Peptide Sciences Tirzepatide 5mg to education and research companies for further study into treating diabetes, protecting the heart and aiding weight loss. For those in research our Tirzepatide Price is the best online. Plus the more you buy the more money you save:
-3 for $155.00 each and save 4%
-5 for $150.00 each and save 7%
-8 for $145.00 each and save 10%
-10 for $140.00 each and save 13%
How Does Tirzepatide Work?
Tirzepatide is an agonist of glucose-dependent insulin tropic peptide (GIP) and glucagon-related peptide-1 receptor (GLP-1). When taken once a week, it combines the action of both incretins in a new molecule. GIP is a hormone and compliments the GLP-1 receptor agonists effects.
In preclinical models, GIP can reduce food intake and increase energy expenditure, leading to weight loss. It may have more pronounced effects on blood sugar and body weight when combined with a GLP-1 receptor agonist. Tirzepatide in a phase III study looking at blood sugar management in adults with type 2 diabetes and long-term weight management. It is also testing as a potential treatment for non-alcoholic steatohepatitis.
Tirzepatide Brand Name
Tirzepatide is a research peptide that derives from the gastric inhibitory polypeptide (GIP). It is similar in functionality to glucagon-like peptide-1 or GLP-1 .
Tirzepatide was initially made to fight type 2 diabetes. But, continuing studies are showing it can protect the heart, and boost weight loss.
In fact Tirzepatide is available now as a type 2 diabetes medication under the brand name of Mounjaro.
Continuing studies are showing it can protect the heart, and boost weight loss. The Tirzepatide peptide is given under the skin to treat diabetes.
Tirzepatide Side Effects Can Include:
-abdominal pain and discomfort
Safety problems did not appear to have arisen in the study. According to the manufacturer, the side effect profile is comparable to other incretin-based therapies. The most common were nausea (31.0% in the highest versus 9.5% in the placebo group), diarrhea (23.0% versus 7.3%), vomiting (12.2% versus 1.7%) and constipation (11.7% versus 5.8%).
At the highest level, 6.2% of participants discontinued treatment prematurely due to side effects. The overall dropout rate was 14.3% versus 26.4% in the placebo group (presumably due to lack of success).
Tirzepatide Weight Loss
The combined GIP/GLP-1 agonist tirzepatide achieved a weight loss of more than 20% in a study using the highest amount in obese patients.
The glucose-dependent insulin tropic peptide (GIP) and the glucagon-like peptide (GLP-1) form by different cells in the intestine during meals. The two hormones not only promote the release of insulin, which is why they are referred to as incretins (“intestinal secretion of insulin”). They also slow gastric emptying and decrease appetite.
Treatment with the various incretins that have been approved for the treatment of type 2 diabetes in recent years often leads to weight loss, which was initially interpreted as a welcome side effect. Incretins are now also being clinically tested for the treatment of obesity. Semaglutide, a GLP-1 agonist for the treatment of obesity, was approved last year in the United States and recently also in Europe.
Weight loss is comparable to that after bariatric surgery, which is 15% to 25% for gastric bypass. In contrast to surgery, treatment with tirzepatide will probably have to be carried out over the long term, which is likely to involve considerable costs.
Tirzepatide FDA Approval
From May 2022 the FDA approved Mounjaro (tirzepatide) as a medication for adults with Type 2 diabetes. It is a new class of diabetes treatment combining GIP and GLP-1 receptor agonists.
Tirzepatide is a research peptide that has shown promising potential for the treatment of type 2 diabetes and obesity. It belongs to a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are designed to mimic the action of the GLP-1 hormone in the body.
Tirzepatide works by enhancing insulin secretion in response to glucose, suppressing glucagon production (which raises blood sugar levels), and slowing down gastric emptying. These mechanisms collectively help regulate blood sugar levels and promote weight loss, making it a promising candidate for addressing the dual challenges of diabetes and obesity.
As for its FDA (U.S. Food and Drug Administration) approval Tirzepatide is still under clinical trials and not yet approved by the FDA for commercial use. However, the pharmaceutical landscape is ever-changing, and it’s possible that there might be a change in the future.
Can I Buy Tirzepatide?
Tirzepatide is showing good results in treating serious health issues from diabetes to obesity. We supply the research product tirzepatide for study only. Our website is among the leading research suppliers online with a vast selection to buy. We supply premium quality research products that are additive and TFA free. The products are safe and pure and made in the USA.
Explore the future of diabetes and obesity research by purchasing Tirzepatide online through the trusted US research company, Peptide Sciences. With their commitment to quality and authenticity, Peptide Sciences provides a reliable platform to access Tirzepatide for your research needs. Empower your scientific endeavors with confidence and precision by partnering with a leader in the field.